Cargando…
A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions
INTRODUCTION: To integrate and execute a proper preventive plan and reduce the risk of non-communicable diseases (NCDs), policy makers need to have access to both reliable data and a unique definition of metabolic syndrome (MetS). This study was conducted on the data collected by cross-sectional stu...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928520/ https://www.ncbi.nlm.nih.gov/pubmed/33657130 http://dx.doi.org/10.1371/journal.pone.0241926 |
_version_ | 1783659874723299328 |
---|---|
author | Tabatabaei-Malazy, Ozra Saeedi Moghaddam, Sahar Rezaei, Nazila Sheidaei, Ali Hajipour, Mohammad Javad Mahmoudi, Negar Mahmoudi, Zohreh Dilmaghani-Marand, Arezou Rezaee, Kamyar Sabooni, Mahdi Razi, Farideh Kompani, Farzad Delavari, Alireza Larijani, Bagher Farzadfar, Farshad |
author_facet | Tabatabaei-Malazy, Ozra Saeedi Moghaddam, Sahar Rezaei, Nazila Sheidaei, Ali Hajipour, Mohammad Javad Mahmoudi, Negar Mahmoudi, Zohreh Dilmaghani-Marand, Arezou Rezaee, Kamyar Sabooni, Mahdi Razi, Farideh Kompani, Farzad Delavari, Alireza Larijani, Bagher Farzadfar, Farshad |
author_sort | Tabatabaei-Malazy, Ozra |
collection | PubMed |
description | INTRODUCTION: To integrate and execute a proper preventive plan and reduce the risk of non-communicable diseases (NCDs), policy makers need to have access to both reliable data and a unique definition of metabolic syndrome (MetS). This study was conducted on the data collected by cross-sectional studies of WHO’s STEPwise approach to surveillance of NCD risk factors (STEPs) to estimate the national and sub-national prevalence rates of MetS in Iran in 2016. MATERIALS AND METHODS: The prevalence of MetS was estimated among 18,414 individuals aged ≥25 years living in urban and rural areas of Iran using various definition criteria; National Cholesterol Education Program Adult Treatment Panel III 2004 (ATP III), International Diabetes Federation (IDF), American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), Joint Interim Statement (JIS). Regional IDF (RIDF) and JIS (RJIS) were defined using ethnicity-specific values of waist circumference for the country. RESULTS: National prevalence rate of MetS based on ATP III, IDF, AHA/NHLBI, JIS, RIDF and RJIS criteria were 38.3% (95% CI 37.4–39.1), 43.5% (42.7–44.4), 40.9% (40.1–41.8), 47.6% (46.8–48.5), 32.0% (31.2–32.9), and 40.8% (40.0–41.7), respectively. The prevalence was higher among females, in urban residents, and those aged 65–69 years. MetS was expected to affect about 18.7, 21.3, 20.0, 23.3, 15.7, and 20.0 million Iranians, respectively, based on ATP III, IDF, AHA/NHLBI, JIS, RIDF and RJIS. The two most common components noted in this population were reduced high-density lipoprotein cholesterol (HDL-C) levels and central obesity. CONCLUSION: High prevalence rate of MetS among Iranian adults is alarming, especially among females, urban residents, and the elderly. The JIS definition criteria is more appropriate to determine higher number of Iranians at risk of NCDs. Proper management and prevention of MetS is required to adopt multiple national plans including lifestyle modifications, medical interventions, and public education on NCDs risk factors. |
format | Online Article Text |
id | pubmed-7928520 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-79285202021-03-10 A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions Tabatabaei-Malazy, Ozra Saeedi Moghaddam, Sahar Rezaei, Nazila Sheidaei, Ali Hajipour, Mohammad Javad Mahmoudi, Negar Mahmoudi, Zohreh Dilmaghani-Marand, Arezou Rezaee, Kamyar Sabooni, Mahdi Razi, Farideh Kompani, Farzad Delavari, Alireza Larijani, Bagher Farzadfar, Farshad PLoS One Research Article INTRODUCTION: To integrate and execute a proper preventive plan and reduce the risk of non-communicable diseases (NCDs), policy makers need to have access to both reliable data and a unique definition of metabolic syndrome (MetS). This study was conducted on the data collected by cross-sectional studies of WHO’s STEPwise approach to surveillance of NCD risk factors (STEPs) to estimate the national and sub-national prevalence rates of MetS in Iran in 2016. MATERIALS AND METHODS: The prevalence of MetS was estimated among 18,414 individuals aged ≥25 years living in urban and rural areas of Iran using various definition criteria; National Cholesterol Education Program Adult Treatment Panel III 2004 (ATP III), International Diabetes Federation (IDF), American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), Joint Interim Statement (JIS). Regional IDF (RIDF) and JIS (RJIS) were defined using ethnicity-specific values of waist circumference for the country. RESULTS: National prevalence rate of MetS based on ATP III, IDF, AHA/NHLBI, JIS, RIDF and RJIS criteria were 38.3% (95% CI 37.4–39.1), 43.5% (42.7–44.4), 40.9% (40.1–41.8), 47.6% (46.8–48.5), 32.0% (31.2–32.9), and 40.8% (40.0–41.7), respectively. The prevalence was higher among females, in urban residents, and those aged 65–69 years. MetS was expected to affect about 18.7, 21.3, 20.0, 23.3, 15.7, and 20.0 million Iranians, respectively, based on ATP III, IDF, AHA/NHLBI, JIS, RIDF and RJIS. The two most common components noted in this population were reduced high-density lipoprotein cholesterol (HDL-C) levels and central obesity. CONCLUSION: High prevalence rate of MetS among Iranian adults is alarming, especially among females, urban residents, and the elderly. The JIS definition criteria is more appropriate to determine higher number of Iranians at risk of NCDs. Proper management and prevention of MetS is required to adopt multiple national plans including lifestyle modifications, medical interventions, and public education on NCDs risk factors. Public Library of Science 2021-03-03 /pmc/articles/PMC7928520/ /pubmed/33657130 http://dx.doi.org/10.1371/journal.pone.0241926 Text en © 2021 Tabatabaei-Malazy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Tabatabaei-Malazy, Ozra Saeedi Moghaddam, Sahar Rezaei, Nazila Sheidaei, Ali Hajipour, Mohammad Javad Mahmoudi, Negar Mahmoudi, Zohreh Dilmaghani-Marand, Arezou Rezaee, Kamyar Sabooni, Mahdi Razi, Farideh Kompani, Farzad Delavari, Alireza Larijani, Bagher Farzadfar, Farshad A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions |
title | A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions |
title_full | A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions |
title_fullStr | A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions |
title_full_unstemmed | A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions |
title_short | A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions |
title_sort | nationwide study of metabolic syndrome prevalence in iran; a comparative analysis of six definitions |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928520/ https://www.ncbi.nlm.nih.gov/pubmed/33657130 http://dx.doi.org/10.1371/journal.pone.0241926 |
work_keys_str_mv | AT tabatabaeimalazyozra anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT saeedimoghaddamsahar anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT rezaeinazila anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT sheidaeiali anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT hajipourmohammadjavad anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT mahmoudinegar anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT mahmoudizohreh anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT dilmaghanimarandarezou anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT rezaeekamyar anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT saboonimahdi anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT razifarideh anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT kompanifarzad anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT delavarialireza anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT larijanibagher anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT farzadfarfarshad anationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT tabatabaeimalazyozra nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT saeedimoghaddamsahar nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT rezaeinazila nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT sheidaeiali nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT hajipourmohammadjavad nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT mahmoudinegar nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT mahmoudizohreh nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT dilmaghanimarandarezou nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT rezaeekamyar nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT saboonimahdi nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT razifarideh nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT kompanifarzad nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT delavarialireza nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT larijanibagher nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions AT farzadfarfarshad nationwidestudyofmetabolicsyndromeprevalenceiniranacomparativeanalysisofsixdefinitions |